Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Tommerdahl KL, Bjornstad P, Kendrick J, Cree-Green M, Baumgartner AD, Pyle L, Reusch JEB, Nadeau KJ. Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes. Diabetes Obes Metab. 2021 03; 23(3):844-849.

View in: PubMed

subject areas

Adolescent
Albuminuria
Creatinine
Diabetes Mellitus, Type 1
Diabetic Nephropathies
Glomerular Filtration Rate
Humans
Kidney
Metformin

authors with profiles

Laura L Pyle
Kalie Lyn Tommerdahl
Jessica B Kendrick
Petter Mathias Bjornstad
Melanie G. Cree
Jane E . Reusch
Kristen Jane Nadeau

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium